Long-term Safety Considerations The safety profile of sitagliptin: Sitagliptin has been extensively studied in clinical trials and real-world settings, and overall, it has demonstrated a favorable safety profile
These include the inconsistent ingredient labeling , quality control issues, and the lack of peer-reviewed data supporting efficacy and long-term safety
And people really do swear by these, which I want to take seriously without mistaking it for evidence
New treatment modalities for obesity
Many of our patients from San Ramon, Danville, Dublin, and Pleasanton come to us managing conditions like PCOS and semaglutide for weight loss, weight loss after menopause, GLP-1 for insulin resistance, GLP-1 for prediabetes, semaglutide for cardiovascular health, GLP-1 for metabolic syndrome, semaglutide for fatty liver (MASH), GLP-1 for sleep apnea, and hormone-related weight gain and hormonal obesity all conditions where GLP-1 therapy can address multiple health issues simultaneously